New Delhi, Dec. 13 -- AIIMS Delhi has made history in stroke care with India's first dedicated clinical trial of the advanced Supernova Stent, a brain stent designed for treating severe strokes.

The GRASSROOT Trial results, published in the Journal of NeuroInterventional Surgery (JNIS), a publication of the prestigious British Medical Journal group, demonstrate excellent safety and efficacy.

AIIMS New Delhi was the national coordinating centre and the lead enrolling site for the GRASSROOT Trial, India's first clinical trial of a new and advanced stroke treatment device, the Supernova Stent.

"This trial is a turning point for stroke treatment in India," said Dr Shailesh B Gaikwad, Professor & Head, Department of Neuroimaging & Intervent...